Cue Biopharma Ownership | Who Owns Cue Biopharma?


OverviewForecastRevenueFinancialsChartTranscripts

Cue Biopharma Ownership Summary


Cue Biopharma is owned by 18.17% institutional investors, 0.35% insiders, and 81.48% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 7.14% of CUE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.18% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCue Biopharma18.17%0.35%81.48%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bleichroeder lp6.82M7.14%$4.65M
Vanguard group2.06M4.01%$2.24M
Catalytic wealth ria3.33M3.49%$2.27M
Blackrock756.74K1.53%$938.35K
Geode capital management631.28K1.23%$688.25K
Northern trust350.42K0.71%$434.52K
Robertson stephens wealth management478.50K0.50%$326.48K
Bank of america corp /de/242.57K0.49%$300.78K
Blackrock funding, inc. /de449.16K0.47%$306.46K
Stifel financial211.36K0.41%$230.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bleichroeder lp6.82M1.14%$4.65M
Catalytic wealth ria3.33M0.19%$2.27M
Advisory research257.23K0.03%$175.50K
Robertson stephens wealth management478.50K0.01%$326.48K
Salzhauer michael16.00K0.01%$10.92K
Angeles wealth management120.00K0.01%$81.88K
Navalign25.00K0.00%$17.06K
Prevail innovative wealth advisors18.99K0.00%$12.96K
Chicago partners investment group88.30K0.00%$78.59K
Texas capital bank wealth management services33.10K0.00%$22.59K

Top Buyers

HolderShares% AssetsChange
Catalytic wealth ria3.33M0.19%3.33M
Bleichroeder lp6.82M1.14%1.82M
Geode capital management631.28K0.00%122.45K
Angeles wealth management120.00K0.01%120.00K
Lpl financial42.93K-25.00K

Top Sellers

HolderShares% AssetsChange
Slate path capital lp---2.40M
Blackrock756.74K--1.49M
Good life advisors---400.00K
Renaissance---274.03K
Sigma planning55.50K0.00%-270.76K

New Positions

HolderShares% AssetsChangeValue
Catalytic wealth ria3.33M0.19%3.33M$2.27M
Angeles wealth management120.00K0.01%120.00K$81.88K
Prevail innovative wealth advisors18.99K0.00%18.99K$12.96K
Salzhauer michael16.00K0.01%16.00K$10.92K
Raymond james financial3.35K-3.35K$2.29K

Sold Out

HolderChange
Assetmark-2.00
Nelson, van denburg & campbell wealth management group-7.00
Farther finance advisors-43.00
Citigroup-43.00
Innealta capital-49.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202546-9.80%17,348,74552.15%187.71%1812.50%9-30.77%
Mar 31, 202551-10.53%11,402,706-3.03%152.91%16-48.39%13116.67%
Dec 31, 2024555.77%11,733,877-15.65%223.11%30150.00%6-64.71%
Sep 30, 202451-32.00%13,910,2910.71%273.48%13-61.76%17-15.00%
Jun 30, 202475-5.06%13,812,235-15.72%272.18%3447.83%20-28.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.35M2.18%-1.00
Vanguard Total Stock Mkt Idx Inv1.53M2.00%-33.38K
Vanguard Institutional Extnd Mkt Idx Tr973.98K1.27%-614.71K
Fidelity Extended Market Index346.77K0.46%-905.00
NT R2000 Growth Index Fund - NL103.76K0.17%-
BlackRock Extended Equity Market K103.23K0.17%-44.00
NT R2000 Index Fund - NL89.94K0.15%-9.65K
Fidelity Total Market Index108.58K0.14%-
Extended Equity Market Fund K100.14K0.13%-2.00K
iShares Micro-Cap ETF99.35K0.13%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 16, 2024PASSERI DANIEL R CHIEF EXECUTIVE OFFICERBuy$30.90K
Aug 25, 2023Suri Anish PRESIDENT AND CSOBuy$11.04K
Aug 14, 2023PASSERI DANIEL R CHIEF EXECUTIVE OFFICERBuy$8.58K
Mar 23, 2023Kiener Peter A-Sell$30.59K
May 27, 2022Morich Frank Buy$105.00K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q41-
2024 Q3--
2024 Q2--

CUE Ownership FAQ


Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 18.17%, followed by 0.35% insiders and 81.48% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 306.59%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (6.82M shares, 7.14%), Vanguard group (2.06M shares, 4.01%), and Catalytic wealth ria (3.33M shares, 3.49%). Together, they hold 14.65% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Bleichroeder lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 1.14% of its assets in 6.82M Cue Biopharma shares, valued at 4.65M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cue Biopharma shares, with 2.18% of its total shares outstanding invested in 1.35M Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools